A phase I pharmacokinetic (PK) study of TSU-68 plus S-1 and oxaliplatin (SOX) in patients with metastatic colorectal cancer (mCRC) treated with prior chemotherapy

被引：0
|
作者：
Shin, Sang Joon
Ahn, Joong Bae
Jeung, Hei-Cheul
Rha, Sun Young
Roh, Jae Kyung
Ahn, Jung Ryun
Kim, Chan
Chung, Hyun Cheol
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-B8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B8
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A phase I/II study of cetuximab (cet) in combination with S-1 and oxaliplatin (SOX) in first-line treatment for metastatic colorectal cancer (mCRC) (JACCRO CC-06).
    Tsuji, Akihito
    Sunakawa, Yu
    Denda, Tadamichi
    Takinishi, Yasutaka
    Kotaka, Masahito
    Tanioka, Hiroaki
    Shimada, Ken
    Kochi, Mitsugu
    Watanabe, Takanori
    Nakamura, Masato
    Ueda, Hiroto
    Inukai, Michio
    Masuishi, Toshiki
    Tani, Satoshi
    Negoro, Yuji
    Okuno, Tatsuya
    Takeuchi, Masahiro
    Ichikawa, Wataru
    Fujii, Masashi
    Nakajima, Toshifusa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [42] Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer
    Koizumi, W.
    Boku, N.
    Yamaguchi, K.
    Miyata, Y.
    Sawaki, A.
    Kato, T.
    Toh, Y.
    Hyodo, I.
    Nishina, T.
    Furuhata, T.
    Miyashita, K.
    Okada, Y.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 766 - 771
  • [43] Phase I/II study of S-1/LV plus oxaliplatin (SOL) for untreated metastatic colorectal cancer: Preliminary report of the phase I part
    Yamazaki, K.
    Yoshino, T.
    Boku, N.
    Kojima, T.
    Onozawa, Y.
    Hironaka, S.
    Fukutomi, A.
    Yasui, H.
    Taku, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Phase I dose-escalating study of S-1 in combination with oxaliplatin for patients with advanced and/or metastatic colorectal cancer
    Li, Jin
    Yin, Jiliang
    Zhu, Xiaodong
    Liu, Yanfei
    Cao, Junning
    Lu, Fangfang
    Zuo, Yunxia
    ANTI-CANCER DRUGS, 2008, 19 (07) : 745 - 748
  • [45] The SOFT trial: a Phase III study of the dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine S-1 and oxaliplatin (SOX) plus bevacizumab as first-line chemotherapy for metastatic colorectal cancer
    Nakamura, Masato
    Yamada, Yasuhide
    Muro, Kei
    Takahashi, Keiichi
    Baba, Hideo
    Sasaki, Yasutsuna
    Komatsu, Yoshito
    Satoh, Taroh
    Mishima, Hideyuki
    Watanabe, Masahiko
    Sakata, Yuh
    Morita, Satoshi
    Shimada, Yasuhiro
    Sugihara, Kenichi
    FUTURE ONCOLOGY, 2015, 11 (10) : 1471 - 1478
  • [46] Final results of a pharmacokinetic (PK) study of capecitabine (X) in combination with oxaliplatin (0) for patients (pts) with metastatic colorectal cancer (MCRC).
    Gil-Delgad, M
    Bastian, G
    Paule, B
    Spano, JP
    Rixe, O
    Guetz, GD
    Urien, S
    Amaury-Soares, J
    Breau, JL
    Castaing, D
    Khayat, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 292S - 292S
  • [47] Phase II study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC).
    Meyerhardt, JA
    Xhu, A
    Enzinger, PC
    Ryan, DP
    Clark, JW
    Kulke, MH
    Michelini, A
    Vincitore, M
    Thomas, A
    Fuchs, CS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 265S - 265S
  • [48] Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis
    Junshik Hong
    Sae-Won Han
    Hye Seon Ham
    Tae-Yong Kim
    In Sil Choi
    Byung-Su Kim
    Do-Youn Oh
    Seock-Ah Im
    Gyeong Hoon Kang
    Yung-Jue Bang
    Tae-You Kim
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1323 - 1331
  • [49] A randomized phase III study of sox (S-1/oxaliplatin) versus COX (capecitabine/oxaliplatin) in patients with advanced colorectal cancer
    Park, Y. S.
    Lim, H. Y.
    Lee, J.
    Kim, T. W.
    Lee, J.
    Hong, Y. S.
    Kim, S. Y.
    Baek, J. Y.
    Kim, J. H.
    Lee, K.
    Chung, I.
    Cho, S.
    Lee, K. H.
    Shin, S. J.
    Kang, H. J.
    Shin, D.
    Jo, S. J.
    Lee, J. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Phase I study of oral fluoropyrimidine S-1 plus oral leucovorin in patients with metastatic colorectal cancer
    Hyodo, Ichinosuke
    Nishina, Tomohiro
    Boku, Narikazu
    Yoshino, Takayuki
    Narahara, Hiroyuki
    Sugimoto, Naotoshi
    ANNALS OF ONCOLOGY, 2006, 17 : 120 - 121
12345